Cargando…
Identification and Simultaneous Determination of the Main Toxical Pyrrolizidine Alkaloids in a Compound Prescription of Traditional Chinese Medicine: Qianbai Biyan Tablet
Qianbai biyan tablet (QT) is a compound prescription of traditional Chinese medicine which is used to treat nasal congestion, rhinitis, and nasosinusitis, with Senecio scandens as its main plant material. Several pyrrolizidine alkaloids (PAs) were reported in Senecio scandens and others of Senecio s...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445730/ https://www.ncbi.nlm.nih.gov/pubmed/34539789 http://dx.doi.org/10.1155/2021/5209618 |
_version_ | 1784568712328642560 |
---|---|
author | Yang, Mengting Tan, Daopeng Lu, Anjing Qin, Lin Wang, Changhong Ling, Hua Lu, Yanliu He, Yuqi |
author_facet | Yang, Mengting Tan, Daopeng Lu, Anjing Qin, Lin Wang, Changhong Ling, Hua Lu, Yanliu He, Yuqi |
author_sort | Yang, Mengting |
collection | PubMed |
description | Qianbai biyan tablet (QT) is a compound prescription of traditional Chinese medicine which is used to treat nasal congestion, rhinitis, and nasosinusitis, with Senecio scandens as its main plant material. Several pyrrolizidine alkaloids (PAs) were reported in Senecio scandens and others of Senecio species. Although Senecio scandens is assigned as the legal plant material of QT, whether replaced use of it by other Senecio plants can bring toxicity is unknown because of the lack of quantitative data about toxic PAs between different Senecio species. In the present study, adonifoline, senkirkine, and another PA presumed as emiline have been identified in QT; however, there was no senecionine detected in all tablets. PA contents in QTs varied in different companies and different batches. Adonifoline existed only in Senecio scandens, and senecionine was detected in all eight Senecio plants investigated in the present study. Data showed that replaced use of Senecio scandens with a low level of senecionine by other Senecio plants such as Senecio vulgaris containing a high level of senecionine is advertised to be forbidden. Data of the present study may be used as a reference to make new drug quality regularity and recommendation guideline for the safety of QT. |
format | Online Article Text |
id | pubmed-8445730 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-84457302021-09-17 Identification and Simultaneous Determination of the Main Toxical Pyrrolizidine Alkaloids in a Compound Prescription of Traditional Chinese Medicine: Qianbai Biyan Tablet Yang, Mengting Tan, Daopeng Lu, Anjing Qin, Lin Wang, Changhong Ling, Hua Lu, Yanliu He, Yuqi Int J Anal Chem Research Article Qianbai biyan tablet (QT) is a compound prescription of traditional Chinese medicine which is used to treat nasal congestion, rhinitis, and nasosinusitis, with Senecio scandens as its main plant material. Several pyrrolizidine alkaloids (PAs) were reported in Senecio scandens and others of Senecio species. Although Senecio scandens is assigned as the legal plant material of QT, whether replaced use of it by other Senecio plants can bring toxicity is unknown because of the lack of quantitative data about toxic PAs between different Senecio species. In the present study, adonifoline, senkirkine, and another PA presumed as emiline have been identified in QT; however, there was no senecionine detected in all tablets. PA contents in QTs varied in different companies and different batches. Adonifoline existed only in Senecio scandens, and senecionine was detected in all eight Senecio plants investigated in the present study. Data showed that replaced use of Senecio scandens with a low level of senecionine by other Senecio plants such as Senecio vulgaris containing a high level of senecionine is advertised to be forbidden. Data of the present study may be used as a reference to make new drug quality regularity and recommendation guideline for the safety of QT. Hindawi 2021-09-09 /pmc/articles/PMC8445730/ /pubmed/34539789 http://dx.doi.org/10.1155/2021/5209618 Text en Copyright © 2021 Mengting Yang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Yang, Mengting Tan, Daopeng Lu, Anjing Qin, Lin Wang, Changhong Ling, Hua Lu, Yanliu He, Yuqi Identification and Simultaneous Determination of the Main Toxical Pyrrolizidine Alkaloids in a Compound Prescription of Traditional Chinese Medicine: Qianbai Biyan Tablet |
title | Identification and Simultaneous Determination of the Main Toxical Pyrrolizidine Alkaloids in a Compound Prescription of Traditional Chinese Medicine: Qianbai Biyan Tablet |
title_full | Identification and Simultaneous Determination of the Main Toxical Pyrrolizidine Alkaloids in a Compound Prescription of Traditional Chinese Medicine: Qianbai Biyan Tablet |
title_fullStr | Identification and Simultaneous Determination of the Main Toxical Pyrrolizidine Alkaloids in a Compound Prescription of Traditional Chinese Medicine: Qianbai Biyan Tablet |
title_full_unstemmed | Identification and Simultaneous Determination of the Main Toxical Pyrrolizidine Alkaloids in a Compound Prescription of Traditional Chinese Medicine: Qianbai Biyan Tablet |
title_short | Identification and Simultaneous Determination of the Main Toxical Pyrrolizidine Alkaloids in a Compound Prescription of Traditional Chinese Medicine: Qianbai Biyan Tablet |
title_sort | identification and simultaneous determination of the main toxical pyrrolizidine alkaloids in a compound prescription of traditional chinese medicine: qianbai biyan tablet |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445730/ https://www.ncbi.nlm.nih.gov/pubmed/34539789 http://dx.doi.org/10.1155/2021/5209618 |
work_keys_str_mv | AT yangmengting identificationandsimultaneousdeterminationofthemaintoxicalpyrrolizidinealkaloidsinacompoundprescriptionoftraditionalchinesemedicineqianbaibiyantablet AT tandaopeng identificationandsimultaneousdeterminationofthemaintoxicalpyrrolizidinealkaloidsinacompoundprescriptionoftraditionalchinesemedicineqianbaibiyantablet AT luanjing identificationandsimultaneousdeterminationofthemaintoxicalpyrrolizidinealkaloidsinacompoundprescriptionoftraditionalchinesemedicineqianbaibiyantablet AT qinlin identificationandsimultaneousdeterminationofthemaintoxicalpyrrolizidinealkaloidsinacompoundprescriptionoftraditionalchinesemedicineqianbaibiyantablet AT wangchanghong identificationandsimultaneousdeterminationofthemaintoxicalpyrrolizidinealkaloidsinacompoundprescriptionoftraditionalchinesemedicineqianbaibiyantablet AT linghua identificationandsimultaneousdeterminationofthemaintoxicalpyrrolizidinealkaloidsinacompoundprescriptionoftraditionalchinesemedicineqianbaibiyantablet AT luyanliu identificationandsimultaneousdeterminationofthemaintoxicalpyrrolizidinealkaloidsinacompoundprescriptionoftraditionalchinesemedicineqianbaibiyantablet AT heyuqi identificationandsimultaneousdeterminationofthemaintoxicalpyrrolizidinealkaloidsinacompoundprescriptionoftraditionalchinesemedicineqianbaibiyantablet |